ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 155 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2021. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $37,000 | +42.3% | 10,300 | -0.2% | 0.00% | – |
| Q4 2020 | $26,000 | 0.0% | 10,317 | 0.0% | 0.00% | – |
| Q3 2020 | $26,000 | -23.5% | 10,317 | +0.2% | 0.00% | – |
| Q2 2020 | $34,000 | +36.0% | 10,300 | -0.2% | 0.00% | – |
| Q1 2020 | $25,000 | -49.0% | 10,320 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $49,000 | +11.4% | 10,320 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $44,000 | -26.7% | 10,320 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $60,000 | +50.0% | 10,320 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $40,000 | +110.5% | 10,320 | 0.0% | 0.00% | – |
| Q4 2018 | $19,000 | -42.4% | 10,320 | 0.0% | 0.00% | – |
| Q3 2018 | $33,000 | -17.5% | 10,320 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $40,000 | 0.0% | 10,320 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $40,000 | -7.0% | 10,320 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $43,000 | -31.7% | 10,320 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $63,000 | -1.6% | 10,320 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $64,000 | – | 10,320 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 15,461,829 | $2,037,869 | 0.36% |
| MSD Partners, L.P. | 15,151,516 | $1,996,970 | 0.16% |
| MSD Partners, L.P. | 7,575,758 | $998,485 | 0.08% |
| MAGNOLIA CAPITAL ADVISORS LLC | 865,938 | $65,552 | 0.03% |
| Allred Capital Management, LLC | 253,000 | $33,345 | 0.02% |
| CHIRON CAPITAL MANAGEMENT, LLC | 77,023 | $10,152 | 0.01% |
| Boxer Capital, LLC | 1,100,000 | $144,980 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 569,566 | $75 | 0.01% |
| Sugarloaf Wealth Management, LLC | 75,500 | $9,951 | 0.00% |
| Owen LaRue, LLC | 11,825 | $1,559 | 0.00% |